A National Perspective on the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic

This OncLive® webinar will focus on the impact of COVID-19 in patients with breast cancer and the innovative ways in which treatment has evolved during this time. We will feature a panel of experts from the nation’s leading cancer centers, led by Eric P. Winer, MD, to discuss important topics and key information for treating patients with breast cancer. Topics/Objectives: Regional differences in the management of patients with breast cancer during the COVID-19 pandemic Institutional best practices for treating patients with breast cancer that have the novel coronavirus or who may be at risk for developing it Guidelines on the prioritization and management of patients with breast cancer Speakers: Eric P. Winer, MD Professor, Medicine, Harvard Medical School Director, Breast Oncology Center, Dana-Farber Cancer Institute Physician Active Staff, Medicine, Brigham And Women's Hospital Thompson Chair, Breast Cancer Research, Dana-Farber Cancer Institute Lisa A. Carey, MD , FASCO Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research Deputy Director of Clinical Sciences Lineberger Comprehensive Cancer Center George W. Sledge Jr, MD Professor, Medicine and Oncology Chief of the Division of Oncology, Stanford University Medical Center Monica Morrow, MD, FACS Chief, Breast Service, Department of Surgery Anne Burnett Windfohr Chair of Clinical Oncology Memorial Sloan Kettering Cancer Center Professor of Surgery, Weill Cornell Medical College Sponsored by : Novartis / In association with Dana Farber